Viewing Study NCT01263457


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-01-29 @ 8:34 AM
Study NCT ID: NCT01263457
Status: COMPLETED
Last Update Posted: 2021-05-05
First Post: 2010-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Growth Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Growth disorders View
None Saizen View
None EasypodTM View
None Growth hormone View
None Pediatric subject View